SalivaTec, a startup in Yamagata prefecture, is working on a “Saliva checker” which detects markers for pancreatic and colon cancer early using metabolomics. In September 2017, the company tied up with Nippon Life Insurance Co. At present, a cohort of 1000 employees of Nippon Life will provide saliva samples for validation of SalivaTec’s approach.

Nikkei Biotech news release, January 18, 2018